Latest news
Cardiac drug developer Braveheart banks more than $382M in IPO - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 03:18:37 GMTNovo setback casts doubt on a new way to treat heart disease - BioPharma DiveBioPharma Dive · Fri, 31 Jul 2026 07:00:00 GMTCapricor Duchenne cell therapy voted down by FDA panel - BioPharma DiveBioPharma Dive · Wed, 29 Jul 2026 07:00:00 GMT